Skip to main content
Clinical Trials/NCT04071717
NCT04071717UnknownNot Applicable

Real-time Neurofeedback Regulating Brain Cognitive Function in Obese Individuals: a Near-infrared Spectroscopy-based Study.

Wu Wenjun-11 site in 1 country90 target enrollmentStarted: January 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
Change of Body Mass Index

Study Overview

Brief Summary

To determine the efficacy of real-time fNIRS neurofeedback for regulating the brain cognitive function in obese individuals.

Detailed Description

In the current study, 60 obese subjects will be recruited, and they were randomly classified into the group who will receive real neurofeedback and the group who will receive sham neurofeedback. Participants will receive the real-time neurofeedback for 12 times, 3 to 4 times a week, each time the real-time neurofeedback consists of 12 sessions of liftstone as the index reflecting the brain activity. Sham group will receive the identical neurofeedback.

All of the subjects will undergo magnetic resonance imaging scan, during which T1, diffusion tensor imaging, resting-state, and task fMRI data will be collected. For task Fmri scan, the participants will be asked to finish four cognitive task, including 2-Back working memory, Go/No-Go task, Willingness to Pay for Food, and Delay Discounting tasks. Clinical measurements including BMI, eating behavior, psychiatric status will be assessed. Those aforementioned examinations will be performed at before the neurofeedback, 6th times and the end of the treatment.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Body mass index (BMI) ≥ 25
  • 18 to 65 years old
  • No severe mental disorders(depression; schizophrenia; bipolar disorder; etc.).

Exclusion Criteria

  • Severe dysfunction of heart, liver, kidney and hematopoietic system
  • Substance addiction
  • Patients who cannot be treated with fMRI or fNRIS neurofeedback
  • Those who take other weight loss drugs.

Arms & Interventions

NIRS group

Experimental

Participants with obesity, 12 sessions of NIRS feedback

Intervention: NIRS neurofeedback (Behavioral)

Sham NIRS group

Sham Comparator

Participants with obesity, 12 sessions of sham NIRS feedback

Intervention: Sham NIRS neurofeedback (Behavioral)

Healthy control group

Other

Healthy participants, 12 sessions of NIRS feedback

Intervention: NIRS neurofeedback (Behavioral)

Outcomes

Primary Outcomes

Change of Body Mass Index

Time Frame: Baseline, through study completion, an average of 6 weeks

Change of the degree of obesity and health of the body

Secondary Outcomes

  • Working Memory(Baseline, through study completion, an average of 6 weeks)
  • Change of Result of Willingness to Pay for Food(Baseline, through study completion, an average of 6 weeks)
  • Change of Result of Go/No-Go(Baseline, through study completion, an average of 6 weeks)

Investigators

Sponsor
Wu Wenjun-1
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Wu Wenjun-1

Clinical physician

Xijing Hospital

Study Sites (1)

Loading locations...

Similar Trials